Bringing Unrivaled Clarity to Complexity

Predictive, actionable biological intelligence for transplant medicine – enabling clinicians to more confidently optimize therapy, inform biopsy decisions, and stratify risk for complex patients

Explore Our Tests

Our Products

Our portfolio of RNA-based diagnostic signatures provides a more direct and accurate assessment of transplant risk than conventional clinical tests and biomarkers alone. By detecting molecular changes before they become clinically apparent, these validated tests enable earlier, more informed decision-making across the kidney transplant journey.

PTRA™

Stratifies patients undergoing deceased donor kidney transplantation for risk of acute rejection in the two months post-transplant.

Learn More

Tutivia^®

Classifies kidney transplant recipients as low or high risk of acute rejection

Learn More

Protega™

Classifies kidney transplant recipients as either low or high risk for developing progressive fibrosis

Learn More

TranscriptTx™

Provides a broader understanding of the biological factors that influence transplant outcomes

Learn More

Our Services

We help researchers and industry partners advance precision medicine innovations. From next generation sequencing (NGS) and bioinformatics to proteomics, we provide the capabilities needed to move breakthrough ideas forward.

Learn More

Latest News

Verici Dx Named Olink® Certified Service Provider

August 10, 2026

Olink, part of Thermo Fisher’s Life Sciences Solutions and Verici Dx sign a certified service agreement and undertake cooperative marketing activities Combining advanced proteomics technology with Verici’s technical laboratory skills and bioinformatics expertise within a CAP/CLIA/NYSDOH/ISO quality framework enhances biomarker discovery, validation, and application FRANKLIN, Tenn., August 10, 2026 — Verici Dx, (AIM: VRCI), a […]

Keep Reading

See All News

The Verici Dx Commitment

To rigorous, validated science

Operating at the intersection of leading-edge laboratory and data science, we develop and market diagnostic tests rigorously validated across inclusive, real-world patient populations to support real-world clinical transplant decision-making.

To transplant clinicians

We empower transplant clinicians with data driven intelligence and timely insights that support confident, proactive decision-making tailored to each patient’s unique biology.

To transplant patients

By reducing uncertainty and supporting earlier, more targeted clinical decisions, our tests help minimize unnecessary procedures, support timely interventions, and promote the potential for better long-term outcomes.

Bringing Unrivaled Clarity to Complexity

Our Products

PTRA™

Tutivia®

Protega™

TranscriptTx™

Our Services

Latest News

Verici Dx Named Olink® Certified Service Provider

The Verici Dx Commitment

To rigorous, validated science

To transplant clinicians

To transplant patients

Tutivia^®